Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Participants
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2020-06-19
- Lead Sponsor
- Turgut İlaçları A.Ş.
- Target Recruit Count
- 168
- Registration Number
- NCT04439929
- Locations
- 🇩🇪
PAREXEL International GmbH, Early Phase Clinical Unit Berlin, Berlin, Germany
News
No news found